Jeffrey L. Cummings

Specialty: Alzheimer’s Drug Development

Location: Unknown

Tier: ELITE

H-Index: 196

Years Active: 0

Hospital Affiliations

• University of Nevada, Las Vegas - Faculty

Key Publications

1. "The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment." - J Am Geriatr Soc (2005)
2. "The Amyloid-β Pathway in Alzheimer's Disease." - Mol Psychiatry (2021)
3. "Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group." - Lancet Neurol (2021)
4. "Alzheimer's disease." - Nat Rev Dis Primers (2015)
5. "A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody." - Alzheimers Res Ther (2021)

Knowledge Graph Relationships

Jeffrey L. Cummings is a Alzheimer’s Drug Development specialist affiliated with University of Nevada, Las Vegas. Authored 5 scholarly articles.